openPR Logo
Press release

Fetal Monitoring Devices Market Set for Steady Growth at 6.34% CAGR Through 2034: DelveInsight | Philips, GE Healthcare, and Natus Medical

03-18-2026 01:04 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Fetal monitoring devices market Insights

Fetal monitoring devices market Insights

The global fetal monitoring devices market is set for strong, sustained expansion, driven by companies such as General Electric Company (GE Healthcare), Koninklijke Philips N.V., FUJIFILM Holdings Corporation, Cardinal Health, Inc., Siemens Healthcare GmbH, Natus Medical Incorporated, Huntleigh Healthcare Limited, Clinical Computer Systems, Inc., Edan Instruments, Inc., Neoventa Medical AB, Arjo, Bionet, Contec Medical Systems Co., Ltd. and others.
The global fetal monitoring devices market is set for strong, sustained expansion, driven by increasing high-risk pregnancies, rising focus on maternal-fetal outcomes, and rapid adoption of advanced monitoring technologies across key geographies.

Key Takeaways

*
The global fetal monitoring devices market is projected to grow from USD 4,148.39 million in 2025 to USD 7,176.97 million by 2034, reflecting a CAGR of 6.34% during 2026-2034.

*
North America is expected to dominate the market in 2025, capturing around 41% share, supported by advanced healthcare infrastructure, higher prevalence of high-risk pregnancies, and strong adoption of AI-enabled and wireless monitoring systems.

*
Fetal Monitoring Devices market growth is underpinned by increasing maternal age, obesity and lifestyle-related risk factors, rising institutional deliveries, and policy focus on reducing maternal and neonatal mortality.

*
Technological trends include integration of AI and analytics, wireless and remote monitoring, and comprehensive maternal-fetal monitoring platforms that enhance workflow efficiency and clinical decision-making.

*
By product and modality, demand is rising for electronic fetal monitors, cardiotocography (CTG) systems, Doppler devices, and integrated maternal-fetal monitoring systems across hospital and specialty clinic settings.

*
Key companies operating in the fetal monitoring devices market include General Electric Company (GE Healthcare), Koninklijke Philips N.V., FUJIFILM Holdings Corporation, Cardinal Health, Inc., Siemens Healthcare GmbH, Natus Medical Incorporated, Huntleigh Healthcare Limited, Clinical Computer Systems, Inc., Edan Instruments, Inc., Neoventa Medical AB, Arjo, Bionet, Contec Medical Systems Co., Ltd., Shenzhen Comen Medical Instruments Co., Ltd., Luckcome, Promed Group, CooperSurgical Inc., Sunray Medical Apparatus Co., Ltd., Dixion, Monica Healthcare and others.

*
Recent developments focus on AI-driven interpretation, connectivity with hospital EMR systems, and expanded deployment in both developed and emerging markets to support better pregnancy surveillance.

For more recent advancements in this landscape, visit Fetal Monitoring Devices Market Recent Developments [https://www.delveinsight.com/sample-request/fetal-monitoring-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]

Fetal Monitoring Devices Market Overview and Growth Outlook

The fetal monitoring devices market is forecast to expand from USD 4,148.39 million in 2025 to USD 7,176.97 million by 2034, growing at a CAGR of 6.34% from 2026 to 2034. This trajectory reflects increasing clinical emphasis on early detection of fetal distress, broader access to institutional births, and sustained investment in obstetric care infrastructure.

Dive deeper into the Fetal Monitoring Devices market trends @ Fetal Monitoring Devices Market insights and analysis [https://www.delveinsight.com/sample-request/fetal-monitoring-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr].

Fetal Monitoring Devices Market Regional Insights

North America is anticipated to hold the largest share of approximately 41% of the global market in 2025, driven by high adoption of advanced medical technologies, favorable reimbursement, and a strong presence of leading manufacturers.

Furthermore, Europe is expected to remain a key growth engine supported by strong public healthcare systems, high standards of prenatal care, and policies focused on reducing maternal and neonatal mortality, while other regions also show rising adoption of technologically advanced monitoring solutions.

For in-depth regional analysis, visit Fetal Monitoring Devices Market Regional analysis and market share [https://www.delveinsight.com/sample-request/fetal-monitoring-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]

Fetal Monitoring Devices Market Segmentation

*
By Product: Ultrasound Devices (2D; 3D & 4D Ultrasound), Electronic Maternal/Fetal Monitors, Fetal Doppler Devices, Telemetry Devices, Others

*
By Method: Invasive, Non-Invasive

*
By Portability: Portable, Non-Portable

*
By End-User: Hospitals, Obstetrics & Gynecology Clinics, Others

Fetal Monitoring Devices Market Competitive Landscape

The competitive landscape is moderately concentrated, with several well-established multinational players complemented by innovative emerging companies.

Key global players include General Electric Company (GE Healthcare), Koninklijke Philips N.V., FUJIFILM Holdings Corporation, Cardinal Health, Inc., Siemens Healthcare GmbH, Natus Medical Incorporated, Huntleigh Healthcare Limited, Clinical Computer Systems, Inc., Edan Instruments, Inc., Neoventa Medical AB, Arjo, Bionet, Contec Medical Systems Co., Ltd., Shenzhen Comen Medical Instruments Co., Ltd., Luckcome, Promed Group, CooperSurgical Inc., Sunray Medical Apparatus Co., Ltd., Dixion, Monica Healthcare and others.

Which company is expected to dominate the Fetal Monitoring Devices market? Know @ Fetal Monitoring Devices Competitive landscape [https://www.delveinsight.com/sample-request/fetal-monitoring-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr].

Key Features of DelveInsight's Fetal Monitoring Devices Market Report

*
Detailed market sizing and forecasts from 2025 to 2034 at global and regional levels, including revenue projections and CAGR analysis.

*
Granular assessment of market contribution by major regions such as North America, Europe, and other high-growth markets.

*
Coverage of key product categories, including electronic fetal monitors, cardiotocography systems, Doppler devices, and integrated maternal-fetal monitoring solutions.

*
Evaluation of usage across care settings, including hospitals, maternity centers, and other clinical environments where fetal monitoring is routinely performed.

*
Detailed discussion on why North America is expected to dominate, including drivers such as high-risk pregnancies, technological adoption, and reimbursement support.

*
Insight into Europe's growth drivers, including public healthcare infrastructure, prenatal care standards, and emphasis on early complication detection.

*
Systematic coverage of demand drivers such as increasing advanced maternal age, obesity-related complications, and growing awareness of fetal well-being monitoring.

*
Identification of evolving opportunities around AI-enabled interpretation, wireless monitoring, remote connectivity, and integration with hospital information systems.

*
Profiles and strategic analysis of major companies in the Fetal Monitoring Devices landscape.

*
Assessment of market concentration, technology adoption trends, and strategic levers for market entry or expansion.

Request Custom Analysis or Speak to Our Analyst @ Fetal Monitoring Devices Market Report [https://www.delveinsight.com/sample-request/fetal-monitoring-devices-market?utm_source=abnewswire&utm_medium=pressrelease&utm_campaign=xpr]

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Arpit Anand
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=fetal-monitoring-devices-market-set-for-steady-growth-at-634-cagr-through-2034-delveinsight-philips-ge-healthcare-and-natus-medical]
Phone: +14699457679
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/consulting/due-diligence-services

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Fetal Monitoring Devices Market Set for Steady Growth at 6.34% CAGR Through 2034: DelveInsight | Philips, GE Healthcare, and Natus Medical here

News-ID: 4428670 • Views:

More Releases from ABNewswire

Novartis's COSENTYX (Secukinumab) Approved by the FDA for Pediatric Hidradenitis Suppurativa: Only IL-17A Inhibitor Cleared for Adolescents Aged 12+
Novartis's COSENTYX (Secukinumab) Approved by the FDA for Pediatric Hidradenitis …
DelveInsight Analysis: What Novartis's COSENTYX (Secukinumab) Approval by the FDA for Pediatric Hidradenitis Suppurativa Means for the Hidradenitis Suppurativa Treatment Market, Biologic Competition, and Commercial Strategy? On March 13, 2026, Novartis announced that the FDA granted approval for COSENTYX (secukinumab) for the treatment of moderate to severe hidradenitis suppurativa (HS) in pediatric patients aged 12 years and older weighing at least 30 kg. The approval marks the fourth pediatric indication for
Mammography Devices Market Poised for Robust Growth at 8.25% CAGR Through 2034: DelveInsight | Hologic, GE Healthcare, and Siemens Healthineers
Mammography Devices Market Poised for Robust Growth at 8.25% CAGR Through 2034: …
The global mammography devices market is set for strong, sustained expansion, driven by companies such as, SternMed GmbH, FUJIFILM Corporation, Hologic Inc., Planmed OY, General Electric Company (GE Healthcare), Siemens Healthcare GmbH, Koninklijke Philips NV, DMS Group, IMS Giotto S.P.A, General Medical Merate S.p.A, Konica Minolta Inc., Lanmage, Crestream Health, MEDI-FUTURE Inc. and others. The global mammography devices market is set for strong, sustained expansion, driven by rising breast cancer incidence,
Cutaneous Lupus Erythematosus Clinical Trial Pipeline Accelerates as 10+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
Cutaneous Lupus Erythematosus Clinical Trial Pipeline Accelerates as 10+ Pharma …
DelveInsight's, "Cutaneous Lupus Erythematosus Pipeline Insight 2026" report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Cutaneous Lupus Erythematosus pipeline landscape. It covers the Cutaneous Lupus Erythematosus Pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Cutaneous Lupus Erythematosus Pipeline Therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Stay ahead
HER2 Positive Breast Cancer Clinical Trial Pipeline Appears Robust With 50+ Key Pharma Companies Actively Working in the Domain | DelveInsight
HER2 Positive Breast Cancer Clinical Trial Pipeline Appears Robust With 50+ Key …
DelveInsight's, "HER2 Positive Breast Cancer Pipeline Insight, 2026" report provides comprehensive insights about 50+ companies and 55+ pipeline drugs in HER2 Positive Breast Cancer pipeline landscape. It covers the HER2 Positive Breast Cancer pipeline drug profiles, including clinical and nonclinical stage products. It also covers the HER2 Positive Breast Cancer pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products

All 5 Releases


More Releases for Fetal

Global Fetal And Maternal Monitor Market Size by Application, Type, and Geograph …
According to Market Research Intellect, the global Fetal And Maternal Monitor market under the Internet, Communication and Technology category is expected to register notable growth from 2025 to 2032. Key drivers such as advancing technologies, changing consumer behavior, and evolving market dynamics are poised to shape the trajectory of this market throughout the forecast period. Growing awareness of maternal and fetal health, particularly in developing nations, is driving the market for
Fetal Monitoring: Top Companies Revenue Analysis
The Fetal Monitoring Market is expected to register a CAGR of 6.93% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031. Download PDF Brochure @ https://www.theinsightpartners.com/sample/TIPMD00002260/?utm_source=OpenPR&utm_medium=10432 The List of Companies 1. NEOVENTA MEDICAL AB 2. NATUS MEDICAL INCORPORATED 3. SIEMENS HEALTHCARE 4. GENERAL ELECTRIC COMPANY 5. ANALOGIC CORPORATION 6. FUJIFILM SONOSITE 7. PHILIPS HEALTHCARE 8. OSI SYSTEMS, INC 9. MEDTRONIC PLC 10. GETINGE GROUP Fetal Monitoring Market Segmentation Product Product • Ultrasound Devices • Fetal Monitors • Telemetry
[Latest] Fetal Monitoring Systems Market : An Overview
The ""Fetal Monitoring Systems Market"" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023. Growing Demand and Growth Potential in the Global Fetal Monitoring Systems Market, 2024-2031 Verified Market Research's most recent report, ""Fetal Monitoring Systems Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2030,""
2022 Fetal Monitoring Market Analysis, Industry Demand, Size, Sales, Trends Oppo …
The report covers current market growths including market enlargement, partnerships & collaborations, mergers & acquisitions, and new product launches. Moreover, the study includes an absolute financial study, SWOT profile, business policies, newly launched products & services, and a business summary of the market players. This study stakeholders and new business entrants to understand the present market trends and convey new business tactics. It also outlines the strategies adopted by them
Fetal Monitoring Market Size to Reach Valuation of $4.25 Billion by 2027 | Elect …
Growth of the global fetal monitoring market is attributed to increase in incidences of stillbirths, multiple pregnancy, late maternal age, technological advancements, and increase in emphasis on continuous fetal monitoring. Furthermore, rise in investments by governments in healthcare system and hospitals are some of the factors that contribute to the growth of the market. The fetal monitoring market was valued at $2.93 billion in 2019 and is expected to reach $4.25
Fetal Monitoring Market
Fetal monitoring devices are used to monitor the heart rate and movement of the fetus and maternal contractions. In medical terms, fetal monitoring is imperative to constantly monitor health of the unborn baby and ensure a safe birth. Fetal monitoring measures the heart rate of the baby. Healthcare providers perform fetal monitoring during late pregnancy and labor, as that process is crucial for keeping the mother and the child safe